TrialAnnals of the rheumatic diseases2014
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
Arthur Kavanaugh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
178 papers cite itlatest 60 shown
this paperpooled ittrialcites it